OARSI Clinical Trials Recommendations: Design and conduct of clinical trials of rehabilitation interventions for osteoarthritis

被引:61
|
作者
Fitzgerald, G. K. [1 ]
Hinman, R. S. [2 ]
Zeni, J., Jr. [3 ]
Risberg, M. A. [4 ]
Snyder-Mackler, L. [3 ]
Bennell, K. L. [2 ]
机构
[1] Univ Pittsburgh, Dept Phys Therapy, Sch Hlth & Rehabil Sci, Pittsburgh, PA 15219 USA
[2] Univ Melbourne, Dept Physiotherapy, Ctr Hlth Exercise & Sports Med, Melbourne, Vic 3010, Australia
[3] Univ Delaware, Dept Phys Therapy, Newark, DE USA
[4] Oslo Univ Hosp, Dept Orthoped Surg, Norwegian Res Ctr Act Rehabil, Oslo, Norway
关键词
Rehabilitation; Clinical trials; Osteoarthritis; OF-RHEUMATOLOGY CRITERIA; LOW-BACK-PAIN; KNEE OSTEOARTHRITIS; OUTCOME SCORE; HAND OSTEOARTHRITIS; HIP OSTEOARTHRITIS; RESEARCH-SOCIETY; HEALTH-STATUS; ARTHRITIS; RELIABILITY;
D O I
10.1016/j.joca.2015.03.013
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
A Task Force of the Osteoarthritis Research Society International (OARSI) has previously published a set of guidelines for the conduct of clinical trials in osteoarthritis (OA) of the hip and knee. Limited material available on clinical trials of rehabilitation in people with OA has prompted OARSI to establish a separate Task Force to elaborate guidelines encompassing special issues relating to rehabilitation of OA. The Task Force identified three main categories of rehabilitation clinical trials. The categories included non-operative rehabilitation trials, post-operative rehabilitation trials, and trials examining the effectiveness of devices (e.g., assistive devices, bracing, physical agents, electrical stimulation, etc.) that are used in rehabilitation of people with OA. In addition, the Task Force identified two main categories of outcomes in rehabilitation clinical trials, which include outcomes related to symptoms and function, and outcomes related to disease modification. The guidelines for rehabilitation clinical trials provided in this report encompass these main categories. The report provides guidelines for conducting and reporting on randomized clinical trials. The topics include considerations for entering patients into trials, issues related to conducting trials, considerations for selecting outcome measures, and recommendations for statistical analyses and reporting of results. The focus of the report is on rehabilitation trials for hip, knee and hand OA, however, we believe the content is broad enough that it could be applied to rehabilitation trials for other regions as well. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:803 / 814
页数:12
相关论文
共 50 条
  • [31] CONDUCT OF CLINICAL TRIALS
    GALLOWAY, DB
    PETRIE, JC
    STEWART, KB
    WALKER, W
    LANCET, 1974, 1 (7864): : 1001 - 1001
  • [32] THE CONDUCT OF CLINICAL TRIALS
    不详
    NUTRITION REVIEWS, 1957, 15 (10) : 320 - 320
  • [33] DESIGN AND CONDUCT OF CLINICAL TRIALS IN MYOCARDIAL INFARCTION
    REID, DD
    CIRCULATION, 1969, 40 (5S4) : IV91 - &
  • [34] ISSUES IN THE DESIGN AND CONDUCT OF CLINICAL-TRIALS
    HENNEKENS, CH
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1984, 73 (06) : 1473 - 1476
  • [35] A primer on the design, conduct, and interpretation of clinical trials
    Appel, Lawrence J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (06): : 1360 - 1367
  • [36] Advancing rehabilitation clinical trials design
    Bernhardt, Julie
    INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2007, 14 (02): : 52 - 52
  • [37] Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
    Reginster, Jean-Yves
    Cooper, Cyrus
    Rizzoli, Rene
    Kanis, John A.
    Appelboom, Geoff
    Bautmans, Ivan
    Bischoff-Ferrari, Heike A.
    Boers, Maarten
    Brandi, Maria Luisa
    Bruyere, Olivier
    Cherubini, Antonio
    Flamion, Bruno
    Fielding, Roger A.
    Gasparik, Andrea Ildiko
    Van Loon, Luc
    McCloskey, Eugene
    Mitlak, Bruce H.
    Pilotto, Alberto
    Reiter-Niesert, Suzanne
    Rolland, Yves
    Tsouderos, Yannis
    Visser, Marjolein
    Cruz-Jentoft, Alfonso J.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 28 (01) : 47 - 58
  • [38] Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
    Jean-Yves Reginster
    Cyrus Cooper
    René Rizzoli
    John A. Kanis
    Geoff Appelboom
    Ivan Bautmans
    Heike A. Bischoff-Ferrari
    Maarten Boers
    Maria Luisa Brandi
    Olivier Bruyère
    Antonio Cherubini
    Bruno Flamion
    Roger A. Fielding
    Andrea Ildiko Gasparik
    Luc Van Loon
    Eugene McCloskey
    Bruce H. Mitlak
    Alberto Pilotto
    Suzanne Reiter-Niesert
    Yves Rolland
    Yannis Tsouderos
    Marjolein Visser
    Alfonso J. Cruz-Jentoft
    Aging Clinical and Experimental Research, 2016, 28 : 47 - 58
  • [39] OMERACT-OARSI initiative: OARSI set of responder criteria for osteoarthritis (OA) clinical trials revisited.
    Pham, T
    Van der Heijde, D
    Altman, RD
    Anderson, JJ
    Bellamy, N
    Hochberg, M
    Simon, L
    Strand, V
    Woodworth, T
    Dougados, M
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S158 - S158
  • [40] Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria
    Pham, T
    Van Der Heijde, D
    Lassere, M
    Altman, RD
    Anderson, JJ
    Bellamy, N
    Hochberg, M
    Simon, L
    Strand, V
    Woodworth, T
    Dougados, M
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (07) : 1648 - 1654